JAFFE SETH 4/A

Accession 0001209191-23-025251

CIK 0000094845other

View on SEC.gov Company Profile

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 6:29 PM ET

Size

41.1 KB

Accession

0001209191-23-025251

Insider Transaction Report

Form 4/AAmended

Period: 2019-03-25

LEVI STRAUSS & COLEVI

JAFFE SETH

EVP & General Counsel

Transactions

Other
Common Stock
2019-03-25−52,800→ 0 total
Other
Stock Appreciation Rights
2019-03-25−453,320→ 0 total
Exercise: $6.10Exp: 2023-02-09→ Common Stock (453,320 underlying)
Other
Stock Appreciation Rights
2019-03-25+339,610→ 339,610 total
Exercise: $7.42Exp: 2022-02-04→ Class B Common Stock (339,610 underlying)
Other
Common Stock
2019-03-25−228,480→ 52,800 total
Other
Class B Common Stock
2019-03-25+52,800→ 281,280 total
→ Class A Common Stock (52,800 underlying)
Other
Stock Appreciation Rights
2019-03-25+453,320→ 453,320 total
Exercise: $6.10Exp: 2023-02-09→ Class B Common Stock (453,320 underlying)
Other
Stock Appreciation Rights
2019-03-25−74,120→ 0 total
Exercise: $9.60Exp: 2025-01-30→ Common Stock (74,120 underlying)
Other
Class B Common Stock
2019-03-25+228,480→ 228,480 total
→ Class A Common Stock (228,480 underlying)
Other
Stock Appreciation Rights
2019-03-25−339,610→ 0 total
Exercise: $7.42Exp: 2022-02-04→ Common Stock (339,610 underlying)
Other
Stock Appreciation Rights
2019-03-25−279,560→ 0 total
Exercise: $6.45Exp: 2021-02-05→ Common Stock (279,560 underlying)
Other
Stock Appreciation Rights
2019-03-25−44,720→ 0 total
Exercise: $14.88Exp: 2029-01-29→ Common Stock (44,720 underlying)
Other
Stock Appreciation Rights
2019-03-25+74,120→ 74,120 total
Exercise: $9.60Exp: 2025-01-30→ Class B Common Stock (74,120 underlying)
Other
Stock Appreciation Rights
2019-03-25−108,490→ 0 total
Exercise: $6.90Exp: 2024-02-01→ Common Stock (108,490 underlying)
Other
Stock Appreciation Rights
2019-03-25+279,560→ 279,560 total
Exercise: $6.45Exp: 2021-02-05→ Class B Common Stock (279,560 underlying)
Other
Stock Appreciation Rights
2019-03-25+44,720→ 44,720 total
Exercise: $14.88Exp: 2029-01-29→ Class B Common Stock (44,720 underlying)
Other
Stock Appreciation Rights
2019-03-25+108,490→ 108,490 total
Exercise: $6.90Exp: 2024-02-01→ Class B Common Stock (108,490 underlying)

Footnotes (10)

[F1]Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
[F10]25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.
[F2]This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. As a result, certain subsequent instances of withholding of shares to satisfy tax liabilities were reported solely within Table I.
[F3]Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 24,230 RSUs vest on February 1, 2020, (ii) 15,130 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 13,440 RSUs vest in four equal annual installments beginning on January 30, 2020.
[F4]Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.
[F5]Of these SARs: (i) 206,050 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 247,270 SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.
[F6]Of these SARs: (i) 144,430 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 195,180 SARs that are fully vested.
[F7]Of these SARs: (i) 93,190 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 186,370 SARs that are fully vested.
[F8]25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.
[F9]25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

LEVI STRAUSS & CO

CIK 0000094845

→

Entity typeother

Related Parties

filerCIK 0001263162

Filing Metadata

Form type: 4/A
Filed: Apr 20, 8:00 PM ET
Accepted: Apr 21, 6:29 PM ET
Size: 41.1 KB

View on SEC.gov